Brixmor (NYSE: BRX) is a real estate investment trust (REIT) that owns and operates a high-quality, national portfolio of open-air shopping centers. Its 363 retail centers comprise approximately 64 million square feet of prime retail space in established trade areas. The Company strives to own and operate shopping centers that reflect Brixmor's vision "to be the center of the communities we serve" and are home to a diverse mix of thriving national, regional and local retailers. Brixmor is a proud real estate partner to over 5,000 retailers including The TJX Companies, The Kroger Co., Publix Super Markets and Ross Stores.

Brixmor Property Group Inc.

BTIG analyst Justin Zelin maintained a Buy rating on ImmunityBio yesterday and set a price target of $9.00. According to TipRanks, Zelin is a 4-sta...

BTIG Reaffirms Their Buy Rating on ImmunityBio (IBRX)

Roth MKM analyst Boobalan Pachaiyappan maintained a Buy rating on LB Pharmaceuticals, Inc. today and set a price target of $31.00. Pachaiyappan cov...

Roth MKM Keeps Their Buy Rating on LB Pharmaceuticals, Inc. (LBRX)

An announcement from ImmunityBio ( ($IBRX) ) is now available. On January 23, 2026, ImmunityBio, Inc. amended a $505 million Second Amended and Res...

ImmunityBio Amends Major Insider Convertible Note Agreement

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ImmunityBio (IBRX – Research Report) and TransMedics...

Analysts Offer Insights on Healthcare Companies: ImmunityBio (IBRX) and TransMedics Group (TMDX)

Shares of ImmunityBio ($IBRX) extended their rally on Tuesday, climbing more than 17% as heavy trading activity continued to fuel momentum. The sto...

ImmunityBio Stock (IBRX) Keeps Flying as FDA Update Fuels Momentum

An update from Belararox Ltd. ( ($AU:BRX) ) is now available. Belararox has completed its first diamond drill hole at the Toro Central prospect wit...

Belararox Confirms Key Sulphide Zone in First Toro Central Drill Hole at Argentine TMT Project

Belararox Ltd. ( ($AU:BRX) ) has shared an announcement. Belararox Limited has called an Extraordinary General Meeting for 20 February 2026 in Pert...

Belararox Moves to Digital Communications as It Calls Extraordinary General Meeting

An announcement from Belararox Ltd. ( ($AU:BRX) ) is now available. Belararox Ltd has applied to the ASX for quotation of 18,111,100 options (ASX c...

Belararox Seeks ASX Quotation for 18.1 Million Options

ImmunityBio ( ($IBRX) ) has shared an update. On January 14, 2026, ImmunityBio announced that the Saudi Food and Drug Authority granted accelerated...

ImmunityBio Wins Saudi Approvals for ANKTIVA Cancer Therapies

Belararox Ltd. ( ($AU:BRX) ) has shared an update. Belararox Ltd has notified the ASX of a proposed issue of new securities, comprising up to 18,11...

Belararox Plans Issue of 18.1 Million Options in New Capital Raising

An update from Belararox Ltd. ( ($AU:BRX) ) is now available. Belararox Ltd has released a transaction-specific prospectus detailing an offer of up...

Belararox Launches Targeted Free Options Offer to Placement Investors

LB Pharmaceuticals, Inc. received a Buy rating and a $31.00 price target from Roth MKM analyst Boobalan Pachaiyappan today. According to TipRanks, ...

LB Pharmaceuticals, Inc. (LBRX) Receives a New Rating from Roth MKM

Belararox Ltd. ( ($AU:BRX) ) has shared an announcement. Belararox Limited has issued 222,222 fully paid ordinary shares as part of a previously an...

Belararox Issues New Shares Under Placement and Confirms Compliance

Belararox Ltd. ( ($AU:BRX) ) just unveiled an update. Belararox Ltd has applied to the ASX for quotation of additional fully paid ordinary shares u...

Market Cap	$8.06B	P/E Ratio	11.83
52W High	$28.61	52W Low	$22.29
Div Yield	123.0%	Payout Ratio	424.7%
EPS Growth 3Y	7.2%	52W Position	66.8%
Overall Score	83	Value Score	100
Quality Score	60	Technical Score	90

EPS Current Est	$2.24	EPS Next Est	$2.35
EPS Growth Est	+4.9%	DPS Growth 3Y	8.1%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BRX	$26.51	-1.05%	3.04M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BRX	$26.51	-1.0%	3.04M
3
4
5
6

BRX

BRX

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Brixmor Property Group Inc. Data in Excel

Get Brixmor Property Group Inc. Data in Excel